PortfoliosLab logoPortfoliosLab logo
MPWR vs. NBIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MPWR vs. NBIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Monolithic Power Systems, Inc. (MPWR) and Neurocrine Biosciences, Inc. (NBIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MPWR achieves a 74.38% return, which is significantly higher than NBIX's 12.64% return. Over the past 10 years, MPWR has outperformed NBIX with an annualized return of 37.94%, while NBIX has yielded a comparatively lower 13.16% annualized return.


MPWR

1D
-0.77%
1M
-4.43%
YTD
74.38%
6M
67.26%
1Y
121.18%
3Y*
44.43%
5Y*
36.35%
10Y*
37.94%

NBIX

1D
-1.81%
1M
-0.97%
YTD
12.64%
6M
4.55%
1Y
27.80%
3Y*
18.64%
5Y*
10.13%
10Y*
13.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MPWR vs. NBIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MPWR
Monolithic Power Systems, Inc.
74.38%54.45%-5.55%79.78%-27.78%35.49%107.49%54.80%4.49%38.23%
NBIX
Neurocrine Biosciences, Inc.
12.64%3.90%3.60%10.31%40.24%-11.14%-10.83%50.53%-7.96%100.49%

Correlation

The correlation between MPWR and NBIX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Nov 19, 2004

0.28

Fundamentals

Market Cap

MPWR:

$77.67B

NBIX:

$16.52B

EPS

MPWR:

$13.89

NBIX:

$6.53

PE Ratio

MPWR:

113.54

NBIX:

24.46

PEG Ratio

MPWR:

1.43

NBIX:

0.48

PS Ratio

MPWR:

25.93

NBIX:

5.27

PB Ratio

MPWR:

21.12

NBIX:

4.85

Total Revenue (TTM)

MPWR:

$2.96B

NBIX:

$3.10B

Gross Profit (TTM)

MPWR:

$1.63B

NBIX:

$3.05B

EBITDA (TTM)

MPWR:

$861.78M

NBIX:

$881.20M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MPWR vs. NBIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MPWR
MPWR Risk / Return Rank: 9191
Overall Rank
MPWR Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
MPWR Sortino Ratio Rank: 9090
Sortino Ratio Rank
MPWR Omega Ratio Rank: 8888
Omega Ratio Rank
MPWR Calmar Ratio Rank: 9393
Calmar Ratio Rank
MPWR Martin Ratio Rank: 9393
Martin Ratio Rank

NBIX
NBIX Risk / Return Rank: 6868
Overall Rank
NBIX Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
NBIX Sortino Ratio Rank: 6565
Sortino Ratio Rank
NBIX Omega Ratio Rank: 6666
Omega Ratio Rank
NBIX Calmar Ratio Rank: 6868
Calmar Ratio Rank
NBIX Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MPWR vs. NBIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Monolithic Power Systems, Inc. (MPWR) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MPWRNBIXDifference
Sharpe ratioReturn per unit of total volatility

+1.62

Sortino ratioReturn per unit of downside risk

+1.63

Omega ratioGain probability vs. loss probability

1.37

1.19

+0.18

Calmar ratioReturn relative to maximum drawdown

5.43

1.34

+4.09

Martin ratioReturn relative to average drawdown

14.45

2.94

+11.52

MPWR vs. NBIX - Sharpe Ratio Comparison

The current MPWR Sharpe Ratio is 2.51, which is higher than the NBIX Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of MPWR and NBIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MPWR vs. NBIX - Drawdown Comparison

The maximum MPWR drawdown since its inception was -72.27%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for MPWR and NBIX.


Loading charts...

Drawdown Indicators


MPWRNBIXDifference

Max Drawdown

Largest peak-to-trough decline

-72.27%

-97.21%

+24.94%

Max Drawdown (1Y)

Largest decline over 1 year

-22.45%

-20.90%

-1.55%

Max Drawdown (3Y)

Largest decline over 3 years

-51.65%

-42.89%

-8.76%

Max Drawdown (5Y)

Largest decline over 5 years

-51.65%

-42.89%

-8.76%

Max Drawdown (10Y)

Largest decline over 10 years

-51.65%

-46.39%

-5.26%

Current Drawdown

Current decline from peak

-6.66%

-4.54%

-2.12%

Average Drawdown

Average peak-to-trough decline

-17.71%

-43.84%

+26.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.44%

9.49%

-1.05%

Volatility

MPWR vs. NBIX - Volatility Comparison

Monolithic Power Systems, Inc. (MPWR) has a higher volatility of 20.33% compared to Neurocrine Biosciences, Inc. (NBIX) at 9.63%. This indicates that MPWR's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MPWRNBIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.33%

9.63%

+10.70%

Volatility (6M)

Calculated over the trailing 6-month period

37.42%

23.91%

+13.51%

Volatility (1Y)

Calculated over the trailing 1-year period

48.53%

31.38%

+17.15%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.53%

32.73%

+20.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.23%

39.13%

+8.10%

Dividends

MPWR vs. NBIX - Dividend Comparison

MPWR's dividend yield for the trailing twelve months is around 0.42%, while NBIX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
MPWR
Monolithic Power Systems, Inc.
0.42%0.69%0.85%0.63%0.85%0.49%0.55%0.90%1.03%0.71%0.98%1.26%
NBIX
Neurocrine Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MPWR vs. NBIX - Financials Comparison

This section allows you to compare key financial metrics between Monolithic Power Systems, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00M20222023202420252026
804.19M
814.50M
(MPWR) Total Revenue
(NBIX) Total Revenue
Values in USD except per share items

MPWR vs. NBIX - Profitability Comparison

The chart below illustrates the profitability comparison between Monolithic Power Systems, Inc. and Neurocrine Biosciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20222023202420252026
55.3%
98.3%
Portfolio components
MPWR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported a gross profit of 445.07M and revenue of 804.19M. Therefore, the gross margin over that period was 55.3%.

NBIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.

MPWR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported an operating income of 241.15M and revenue of 804.19M, resulting in an operating margin of 30.0%.

NBIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.

MPWR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported a net income of 193.23M and revenue of 804.19M, resulting in a net margin of 24.0%.

NBIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.


Frequently Asked Questions


MPWR and NBIX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MPWR has higher volatility (20.33%) compared to NBIX (9.63%). In terms of maximum drawdown, MPWR dropped -72.27% vs NBIX's -97.21%.

MPWR currently has the higher Sharpe Ratio (2.51 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MPWR and NBIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer